Block 2 Flashcards
Cancer
What is cancer?
uncontrolled, clonal (arising from a single transformed progenitor cell) proliferation of cells uncoordinated with normal tissue proliferations that continues in the absence of stimuli
Benign vs. malignant tumors?
non-cancerous, slow growing, distinct borders (capsulated)
don’t invade surrounding tissue or spread
cells are normal
can still cause health issues
cancerous, grow quickly, irregular borders (non-capsulated)
invade surrounding tissue and spread
cells have large, dark nuclei, can have abnormal shape
often cause death
How can benign tumors cause health issues?
- compression of surrounding tissues and organs
ex) pituitary adenoma pressing on optic nerve - obstruction of passages (blood vessels, airways, digestive tracts)
- hormonal effects: tumors in endocrine glands can disrupt hormone levels
Tumor grade vs. stage?
appearance of cancer cells: nuclear atypia (high N:C ratio), cellular pleomorphism (variation in size and shape), polarity: poorly organized, loss of tissue architecture, tend to grow/spread faster (more mitosis), necrosis
poorly differentiated = higher grade = more abnormal looking
extent of tumor spread from the primary site
high stage = spread to distant parts of the body
TNM staging: tumor size (T1-T4), lymph node number/localization (N1-N3), metastasis (M0-M1)
How are cancers named?
tissue of origin and if they are malignant or benign
malignant: -carcinoma, -sarcoma
benign: -oma
How does cancer lead to death?
- local growth: space filling lesions that can impinge crucial structures and obstruct normal flow (nerves, blood vessels, GI) ; bleeding, infection
- metastasis: replacing normal, functioning tissue; most common = lungs, liver, bones (no immune cells), brain (LOF)
- secretion factors: secrete biological molecules that lead to physiologic dysfunction: pro-clotting factors (cut off blood supply), tumor necrosis factor (cachexia: muscle wasting, fat loss)
What are the three conditions associated with secretion of factors?
Trousseau’s Syndrome: secretion of tissue factor that lead to coagulation
Paraneoplastic Syndrome: secretion of hormones not normally made by those cells that leads to hypercalcemia, hypoglycemia
Cancer Cachexia: pro-inflammatory molecules (TNF) and catabolic factors produced by tumor suppresses appeptite; loss of skeletal muscle and adipose tissue from proteolysis, lipolysis, and futile cycling
What are the agents of mutation that initiate cancer development?
- chemicals: carcinogens can initiate cancer (mutagens) or promote its growth (stimulators): cigarette smoke, alcohol
- UV radiation: also mutagenic (pyrimidine dimers)
- Microbial: viruses (HPV), bacteria (H Pylori), parasites can encode oncogenes or proteins that disable tumor suppressors, can cause chronic inflammation with injury repair, cause immunosuppression
What are the two types of carcinogens?
initiators (mutagens) and promoters (stimulator of growth): need both
inflammation: ROS are mutagenic, growth factors, pro-angiogenic factors
consequences of proliferation
- DNA replication errors
- Telomere shortening
What are the Hallmarks of Cancer?
KEEP dividing/proliferating + avoid being killed
1. sustained proliferative signaling
2. evading growth suppressors
3. avoiding immune destruction
4. enabling replicative immortality
5. tumor-promoting inflammation
6. activating invasion & metastasis
7. inducing or accessing vasculature
8. genome instability and mutation
9. resisting cell death
10. deregulating cellular metabolism
Sustaining proliferative signaling
mutations in growth factor signal transduction cascade (oncogenes)
- Growth Factors: increased expression that permits autocrine signaling
- TGF-alpha, FGF - Receptors: activation without growth factors
- EGF-R in lung - Signal transduction
- RAS: always active + GTP-bound - Transcription Factors: activates cell cycle genes
- MYC: amplifications in breast, colon
translocations in Burkitt Lymphoma - Cell cycle increases
Evading growth suppressors
Together with sustained proliferative signaling (oncogene mutations), you
need co-occurring evasion of growth suppressors (tumor suppressor mutations) to drive tumor development
dysfunction of various genes that arrest the cell cycle: Rb (blocks DNA synthesis) + p53 (regulates cell cycle, DNA repair, apoptosis)
What drives cancer growth?
genetic mishaps: translocation, mutation, amplification, deletion
epigenetic changes: histone modification, DNA methylation
genetic mutations can cause epigenetic changes
Tumor suppressor genes vs. oncogenes?
inhibit cell proliferation and promote apoptosis (p53, BRCA1, BRCA2, Rb); both need to be mutated to lose function
mutations promote cell growth and proliferation (GOF); one mutation required; MYC, RAS, Abl
What is loss of heterozygosity?
one copy of the tumor suppressor gene is lost (inherited or spontaneous); loss of the other copy via mutation or deletion results in inactivation
most common is p53: impaired cell cycle regulation, DNA repair, apoptosis
Resisting Cell Death
genetic changes in the intrinsic apoptosis pathway are very common in cancer
1. anti-apoptotic oncogenes (amplification): BCL2, BCL-xL, MCL-1
2. pro-apoptotic (mutations/decrease expression) tumor suppressor: Bax, Bak
Activating Invasion/Metastasis
tumors are most lethal when they spread
steps
1. epithelial-mesenchymal transition (EMT)
2. invade (leave current tissue)
3. intravasate (get into bloodstream)
4. circulate (move to another place)
5. extravasate (out of bloodstream)
6. colonize (start growing in new tissue)
Why do micrometastases stay dormant?
- anti-growth signals in normal tissue
- incapable of activating angiogenesis
- tumor-suppressing action of immune system
What is the key process of invasion/metastasis?
EMT: epithelial to mesenchymal transition = lose organization, cell-to-cell adhesion, and attachment to basement membrane and gain migratory and invasive properties
Marker epithelial cells: E-cadherin
Marker mesenchymal cells: N-cadherin, vimentin
Enabling Replicative Immortality
increased telomerase expression in cancer cells keeps telomeres long so they can keep dividing and avoid senescence
Tumor-promoting inflammation
not oncogenic itself but allow mutations in other genes during normal cell division
cancer cell can benefit from inflammation
inflammatory cells release ROS cause mutation, and they can also supply growth factors and other tumor survival factors
Deregulating cellular energetics
Warburg effect – cancer cells shift from oxidative phosphorylation to aerobic
glycolysis/lactic acid fermentation to gain biomass: use these breakdown products to make
building blocks for the cell to keep growing (nucleotides, amino acids, lipids)
Inducing Angiogenesis
Tumors need access to nutrients to survive/spread – get this from making new
blood vessels (angiogenesis) via vascular endothelial growth factor (VEGF)
neovasculature is aberrant
- excessive vessel branching
- distorted/enlarged vessels
- erratic blood flow
- leakiness